<SEC-DOCUMENT>0001127602-22-019579-index.html : 20220721
<SEC-HEADER>0001127602-22-019579.hdr.sgml : 20220721
<ACCEPTANCE-DATETIME>20220721163125
ACCESSION NUMBER:		0001127602-22-019579
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220719
FILED AS OF DATE:		20220721
DATE AS OF CHANGE:		20220721

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			DeLong Mark Jeffrey
		CENTRAL INDEX KEY:			0001856078

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38276
		FILM NUMBER:		221097430

	MAIL ADDRESS:	
		STREET 1:		100 5TH AVENUE, 3RD FLOOR
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apellis Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001492422
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				271537290
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		100 FIFTH AVENUE
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		617-977-5700

	MAIL ADDRESS:	
		STREET 1:		100 FIFTH AVENUE
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: form4.html

Document 1 - RAW XML: form4.xml

</DOCUMENT>
</SEC-DOCUMENT>